Ce site à été réalisé à l'aide de différents livres, documents et autres dont :

En français

Du calme ! (Manuel pour l'éducation des enfants hyperactifs)

Les enfants hyperactifs et lunatiques : Dr Guy Falardeau

Protocole pour aider à mieux intervenir auprès des élèves pouvant présenter un déficit d'attention/hyperactivité : C. Desjardins - M. Groulx - S. Lavigueur

L'hyperactivité chez l'enfant. Dugas, M.

L'enfant agité et distrait : J.Corraze/J.M. Albaret

MICOUIN, J., BOUCRIS, J.C. (1988). L’enfant instable ou hyperkinétique: une étude comparée de concepts. Psychiatrie de l’enfant, 31, 2, 473-507.

PERREAULT, D. (1998). Calmer les hyperactifs sans les assommer. Montréal: Le Devoir, 24 février, p. B1.

Apprivoiser l'hyperactivité et le déficit de l'attention : Colette Sauvé

Parents efficaces : Dr Thomas Gordon

Le don de dyslexie : Ronald D.Davis

Hyperactivité et déficit d’attention chez l’enfant Dubé R.

Troubles de l'attention, impulsivité et hyperactivité chez l'enfant : J.Thomas-G.Willems

Ces parents à bout de souffle : un guide de survie à l'intention des parents - Suzanne Lavigueur

Ces enfants qui bougent trop : Dr Claude Desjardins

Des devoirs sans problème : guide pratique à l'intention des parents : Diane Dessaulniers

Gérer les adolescents difficiles - Comportements impulsifs, excessifs ou agités : COMPERNOLLE Th

Hyperactivité avec ou sans déficit d'attention : Un point de vue de l'épidémiologie scolaire : Jean-Marie Honorez

DORÉ, C., COHEN, D. (1996). La prescription de stimulants aux enfants "hyperactifs": une étude pilote des incitatifs et des contraintes pour les parents, les médecins et les enseignants. Santé Mentale au Québec, 22, 1, 216-238.

HONOREZ, J.M. (1995). Le THADA et les problèmes d’attention scolaire. Communication au congrès de la Société Canadienne de Psychologie, Charlottetown.

HONOREZ, J.M. (1997). Les limites en milieu scolaire du paradigme médical du trouble hyperactivité et d’attention, in R. Féger (Éd.): L’éducation face aux nouveaux défis. Actes du 4è congrès des sciences de l’éducation de langue française au Canada (pp. 337-345). Montréal: Éditions Nouvelles.

HONOREZ, J.M. (1998). La transmission des résultats de recherche un devoir social: le cas des travaux sur le Ritalin. Les recherches enseignées en espaces francophones (Université Victor Segalen Bordeaux 2, Bordeaux, France), 1, 83-98.

HONOREZ, J.M., LAGEIX, P. (1996). Hyperactivité-impulsivité et inattention chez des jeunes diagnostiqués THADA selon le D.S.M.. Communication au 26è Congrès International de Psychologie, Montréal.

HONOREZ, J.M., LAGEIX, P., BERTHIAUME, C., BRETON, J.J., BERGERON, L., VALLA, J.P. (1997). Subtypes of attention-deficit hyperactivity disorder at the elementary level. Communication au 5th European congress of psychology, Dublin.

Marquet-Doléac J. Albaret J.M. Bénesteau J. (1999), Manuel du test d'appariement d'images, Paris : Editions du Centre de Psychologie Appliquée

Albaret J.M. Migliore L. (1999), Manuel du test de Stroop (8-15 ans), Paris : Editions du Centre de Psychologie Appliquée

Albaret J.M. Noack N. (1994), Manuel de l'échelle de coordinations motrices de Charlop-Atwell, Paris : Editions du Centre de Psychologie Appliquée

En Anglais :

American Academy of Pediatrics. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics 2001; 108:1033-44.

American Academy of Pediatrics. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 2000; 105:1158-70.

Dulcan M. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997; 36:S85-S121.

Elia J, Ambrosini PJ, Rapoport JL. Treatment of attention-deficit-hyperactivity disorder. N Engl J Med 1999; 340:780-8.

US Surgeon's general report. http://www.surgeongeneral.gov/Library/MentalHealth/chapter3/sec4.html . 2003.

The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal treatment study of children with ADHD. Arch Gen Psychiatry 1999; 56:1073-86.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th Edition (DSM-IV) ed. Washington, DC: American Psychiatric Association, 1994.

Faraone SV, Levy F, Hay DA, McStephen M, Wood C, Wildman I. Attention deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large scale twin study. J Am Acad Child Adolesc Psychiatry 1997; 36:737-44.

Biederman J, Faraone SV. Current concepts on the neurobiology of attention-deficit/hyperactivity disorder. J Atten Disord 2002; 6:S7-16.

Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 1995; 65:1157-65.

Castellanos FX, Lee PP, Sharp W, Jeffries NO, Greenstein DK, Clasen LS et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002; 288:1740-8.

Biederman J. Family-environment risk factors for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1995; 52:464-70.

Rowe KS. Synthetic food colourings and 'hyperactivity': a double-blind crossover study. Aust Paediatr J 1988; 24:143-7.

Wolraich ML, Lindgren SD, Stumbo PJ, Stegink LD, Appelbaum MI, Kiritsy MC. Effects of diets high in sucrose or aspartame on the behavior and cognitive performance of children. N Engl J Med 1994; 330:301-7.

Wolraich ML, Wilson DB, White JW. The effect of sugar on behavior or cognition in children. A meta-analysis. JAMA 1995; 274:1617-21.

Goldman L, Genel M, Bezman R, Slanetz P. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA 1998; 279:1100-7.

Busch B, Biederman J, Cohen LG, Sayer JM, Monuteaux MC, Mick E. Correlates of ADHD among children in pediatric and psychiatric clinics. Psychiatr Serv 2002; 53:1103-11.

Kuhne M, Schachar R, Tannock R. Impact of comorbid oppositional or conduct problems on attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1997; 36:1715-25.

Coffey B, Biederman J, Geller D, Spencer TJ, Kim GS, Bellordre CA et al. Distinguishing illness severity from tic severity in children and adolescents with Tourette's disorder. J Am Acad Child Adolesc Psychiatry 2000; 39:556-61.

Comings DE, Comings BG. Tourette's syndrome and attention deficit disorder. In: Cohen DJ, Bruun RD, Leckman JF, editors. Tourette's Syndrome and Tic Disorders: Clinical Understanding and Treatment. New York, NY: John Wiley and Sons, 1988: 119-136.

Spencer T, Biederman J, Wilens TE, Faraone SV. Adults with attention-deficit/hyperactivity disorder: a controversial diagnosis. J Clin Psychiatry 1998; 59:59-68.

Spencer TJ, Biederman J, Wilens TE, Harding M, O, Donnell D et al. Pharmacotherapy of attention deficit hyperactivity disorder across the lifecycle: a literature review. J Am Acad Child Adolesc Psychiatry 1996; 35:409-432.

Spencer T, Wilens TE, Biederman J, Faraone SV, Ablon JS, Lapey K. A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Arch Gen Psychiatry 1995; 52:434-443.

Wilens TE, Spencer T, Biederman J, Girard K, Doyle R, Prince J et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 2001; 158:282-8.

Jensen PS, Kettle L, Roper MT. Are stimulants overprescribed? Treatment of ADHD in four U.S. communities. J Am Acad Child Adolesc Psychiatry 1999; 38:797-804.

IMS Health Canada. http://www.imshealthcanada.com/htmen/3_1_3.htm . 2003. 6-7-0003.

Gillberg C, Melander H, von Knorring AL, Janols LO, Thernlund G, Hagglof B et al. Long-term stimulant treatment of children with ADHD symptoms: a randomized, double-blind, placebo controlled trial. Arch Gen Psychiatry 1997; 54:865-70.

Klorman R, Brumaghim JT, Fitzpatrick PA, Borgstedt AD. Clinical effects of a controlled trial of methylphenidate on adolescents with attention deficit disorder. J Am Acad Child Adolesc Psychiatry 1990; 29:702-9.

Klein RG. Pharmacotherapy of childhood hyperactivity: an update. In: Meltzer HY, editor. Psychopharmacology: The Third Generation of Progress. New York NY: Raven Press, 1987: 1215-1224.

Rapport MD, Stoner G, DuPaul GJ, Kelly KL, Tucker SB, Schoeler T. Attention deficit disorder and methylphenidate: a multilevel analysis of dose-response effects on children's impulsivity across settings. J Am Acad Child Adolesc Psychiatry 1988; 27:60-69.

Spencer T, Biederman J, Wilens TE. Pharmacotherapy of ADHD: a life span perspective. In: Oldham J, Riba M, editors. American Psychiatric Press Review of Psychiatry. Washington, DC: American Psychiatric Association, 1997: 87-128.

Elia J, Borcherding BG, Rapoport JL, Keysor CS. Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true non-responders? Psychiatry Res 1991; 36:141-155.

Varley CK, Vincent J, Varley P, Calderon R. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications. Compr Psychiatry 2001; 41:22833.

Gadow K, Sverd J, Sprafkin J, Nolan E, Ezor S. Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder. Arch Gen Psychiatry 1995; 52:444-455.

Castellanos FX, Giedd JN, Elia J, Marsh WL, Ritchie GF, Hamburger SD. Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose. J Am Acad Child Adolesc Psychiatry 1997; 36:589-96.

Tourette's Syndrome Study Group. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology 2002; 58:527-36.

Spencer T, Biederman J, Wilens TE. Growth deficits in children with attention deficit hyperactivity disorder. Pediatrics 1998; 102:501-6.

Rapport MD, DuPaul GJ, Kelly KL. Attention deficit hyperactivity disorder and methylphenidate: the relationship between gross body weight and drug response in children. Psychopharmacol Bull 1989; 1989(25):-285.

Mattes JA, Gittelman R. Growth of hyperactive children on maintenance regimen of methylphenidate. Arch Gen Psychiatry 1983; 40:317-21.

Gittelman R, Mannuzza S. Hyperactive boys almost grown up: III. Methylphenidate effects on ultimate height. Arch Gen Psychiatry 1988; 45:1131-4.

Spencer T, Biederman J, Wilens TE. Growth deficits in children with attention deficit hyperactivity disorder. Pediatrics 1998; 102:501-6.

Brown RT, Wynne ME, Slimmer LW. Attention deficit disorder and the effect of methylphenidate on attention, behavioral, and cardiovascular functioning. J Clin Psychiatry 1984; 45:473-6.

Biederman J, Baldessarini RJ, Wright V, Knee D, Harmatz J. A double-blind placebo controlled study of desipramine in the treatment of attention deficit disorder: I. Efficacy. J Am Acad Child Adolesc Psychiatry 1989; 28:777-84.

Biederman J, Gastfriend DR, Jellinek MS. Desipramine in the treatment of children with attention deficit disorder. J Clin Psychopharmacol 1986; 6:359-363.

Gastfriend DR, Biederman J, Jellinek MS. Desipramine in the treatment of attention deficit disorder in adolescents. Psychopharmacol Bull 1985; 21:144-5.

Wilens TE, Biederman J, Geist DE, Steingard R, Spencer T. Nortriptyline in the treatment of attention deficit hyperactivity disorder: A chart review of 58 cases. J Am Acad Child Adolesc Psychiatry 1993; 32:343-9.

Prince JB, Wilens TE, Biederman J. A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 2000; 10:193-204.

Riddle MA, Nelson JC, Kleinman CS, Rasmusson A, Leckman JF, King RA et al. Sudden death in children receiving Norpramin (desipramine): a review of three reported cases and commentary. J Am Acad Child Adolesc Psychiatry 1991; 30:104-8.

Riddle MA, Geller B, Ryan N. Another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiatry 1993; 32:792-7.

Varley CK, McClellan J. Case study: two additional sudden deaths with tricyclic antidepressants. J Am Acad Child Adolesc Psychiatry 1997; 36:390-4.

Biederman J, Thisted R, Greenhill L, Ryan N. Estimation of the association between desipramine and the risk for sudden death in 5- to 14-year-old children. 56 1995;(87):93.

Casat CD, Pleasants DZ, Van Wyck Fleet J. A double-blind trial of bupropion in children with attention deficit disorder. Psychopharmacol Bull 1987; 23:120-2.

Casat CD, Pleasants DZ, Schroeder DH, Parler DW. Bupropion in children with attention deficit disorder. Psychopharmacol Bull 1989; 25:198-201.

Conners K, Casat CD, Gualtieri T, et al. Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 1996; 34:1314-21.

Barrickman LL, Perry PJ, Allen AJ, Kuperman S, Arndt SV, Herrmann KJ et al. Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995; 34:649-57.

Wilens TE, Spencer T, Biederman J, Girard K, Doyle R, Prince J et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 2001; 158:282-8.

Wender PH, Reimherr FW. Bupropion treatment of attention-deficit hyperactivity disorder in adults. Am J Psychiatry 1990; 147:1018-20.

Riggs PD, Leon SL, Mikulich SK, Pottle LC. An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry 1998; 37:1271-8.

Findling R, Schwartz M, Flannery D, Manos M. Venlafaxine in adults with ADHD: an open trial. J Clin Psychiatry 1996; 57:184-9.

Adler LA, Resnick S, Kunz M, Devinsky O. Open-label trial of venlafaxine in adults with attention deficit disorder. Psychopharmacol Bull 1995; 31:785-8.

Olvera RL, Pliszka SR, Luh J, Tatum R. An open trial of venlafaxine in the treatment of attention-deficit/hyperactivity disorder in children and adolescents. J Child Adolesc 1996; 6:24150.

Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee FR et al. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics 2001; 108:83.

Atomoxetine, a non-stimulant, noradrenergic enhancer for ADHD: double-blind treatment results. New York, NY: 2000.

Biederman J, Heiligenstein JH, Faries D, Galil N, Dittmann R, Emslie GJ et al. Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder. Pediatrics 2002; 110:e75.

Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C et al. Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry 2002; 159:1896-901.

Spencer T, Heiligenstein JH, Biederman J, Faries DE, Kratochvil CJ, Conners CK et al. Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2002; 63:1140-7.

Kratochvil CJ, Heiligenstein JH, Dittmann R, Spencer T, Biederman J, Wernicke J et al. Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. J Am Acad Child Adolesc Psychiatry 2002; 41:776-84.

Hunt RD, Minderaa RB, Cohen DJ. Clonidine benefits children with attention deficit disorder and hyperactivity: report. J Am Acad Child Adolesc Psychiatry 1985; 24:617-29.

Hunt R, Arnsten A, Asbell M. An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1995; 34:50-4.

Hunt RD. Treatment effects of oral and transdermal clonidine in relation to methylphenidate: an open pilot study in ADD-H. Psychopharmacol Bull 1987; 23:111-4.

Horrigan JP, Barnhill LJ. Guanfacine for treatment of attention-deficit hyperactivity disorder in boys. J Child Adolesc Psychopharmacol 1995; 1995:215-23.

Parker D, Ahrens C, Trupti M, Larive L. An overview of ADHD: characteristics and treatment options. Michigan Pharmacist 2002;22-35.

Steingard R, Biederman J, Spencer T, Wilens TE, Gonzalez A. Comparison of clonidine response in the treatment of attention deficit hyperactivity disorder with and without comorbid tic disorders. J Am Acad Child Adolesc Psychiatry 1993; 32:350-3.

Scahill L, Chappell PB, Kim YS, Schultz RT, Katsovich L, Shepherd E et al. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 2001; 158:1067-74.

Popper CW. Combining methylphenidate and clonidine: pharmacologic questions and news reports about sudden death. J Child Adolesc Psychopharmacol 1995; 5:157-66.

Fenichel RF. Combining methylphenidate and clonidine: the role of post-marketing surveillance. J Child Adolesc Psychopharmacol 1995; 5:155-6.

Wilens TE, Spencer T. Combining methylphenidate and clonidine: a clinically sound medication option. J Am Acad Child Adolesc Psychiatry 1999; 38:614-22.

Cantwell DP, Swanson J, Connor DF. Case study: adverse response to clonidine. J Am Acad Child Adolesc Psychiatry 1997; 36:539-44.

Gutgesell H, Atkins D, Barst R, Buck M, Franklin W, Humes R et al. Cardiovascular monitoring of children and adolescents receiving psychotropic drugs: A statement for healthcare professionals from the Committee on Congenital Cardiac Defects, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1999; 99:978-82.

Gittelman R. Childhood disorders. In: Klein D, Quitkin F, Rifkin A, Gittelman R, editors. Drug Treatment of Adult and Child Psychiatric Disorders. Baltimore, Md.: Williams and Wilkins, 1980: 576-756.

Simeon J, Milin R, Walker S. A retrospective chart review of risperidone use in treatment-resistant children and adolescents with psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2002; 26:267-75.

Einarson TR, Iskedjian M. Novel antipsychotics for patients with attention-deficit hyperactivity disorder: A systematic review. 17. 2001. Ottawa, Canadian Coordinating Office for Health Technology Assessment (CCOHTA).

Toren P, Laor N, Weizman A. Use of atypical neuroleptics in children and adolescent psychiatry. J Clin Psychiatry 1998; 59:644-56.

Chan E. The role of complementary and alternative medicine in attention-deficit hyperactivity disorder. J Dev Behav Pediatr 2002; 23:S37-45.

Bernard-Bonnin A. The use of alternative medications in treating children with attention deficit hyperactivity disorder. Canadian Pediatric Society Position Statement. Paediatr Child Health 2002; 7:710-8.

Galler JR, Ramsey F, Solimano G. The influence of early malnutrition on subsequent behavioral development. I. Degree of impairment on intellectual performance. J Am Acad Child Adolesc Psychiatry 1983; 22:8-15.

Haslam RH, Dalby JT, Rademaker AW. Effects of megavitamin therapy on children with attention deficit disorders. Pediatrics 1984; 74:103-11.

Jan JE, O'Donnell ME. Use of melatonin in the treatment of paediatric sleep disorders. J Pineal Res 1996; 21:193-9.

Smits M, Nagtegaal E, Valentijn S. Melatonin for chronic sleep onset insomnia in children with attention deficit hyperactivity disorder: Randomized placebo controlled trial. J Neurol Neurosurg Psychiatry 1999; 67:840.

Stubberfield TG, Parry TS. Utilization of alternative therapies in attention-deficit hyperactivity disorder. J Paediatr Child Health 1999; 34:450-3.

Feingold BF. Why your child is hyperactive. New York: 1975.

Mattes JA, Gittelman R. Effects of artificial food colorings in children with hyperactive symptoms: A critical review and results of a controlled study. Arch Gen Psychiatry 1981; 38:7148.

Williams JI, Cram DM, Tausig FT, Webster E. Relative effects of drugs and diet on hyperactive behaviors. An experimental study. Pediatrics 1978; 61:811-7.

Levy F, Dumbrell S, Hobbes G, Ryan M, Wilton N, Woodhill JM. Hyperkinesis and diet: A double-blind crossover trial with a tartrazine challenge. Med J Aust 1978; 1:61-4.

Rowe KS, Rowe KJ. Synthetic food coloring and behavior: A dose response effect in a double-blind, placebo-controlled, repeated measures study. J Pediatr 1994; 125:691-8.

Conners CK, Goyette CH, Southwick DA. Food additives and hyperkinesis: A controlled double-blind experiment. Pediatrics 2003; 58:154-66.

Breakey J. The role of diet and behaviour in children. J Paediatr Child Health 1997; 33:1904.

Wolraich ML, Lindgren SD, Stumbo PJ, Stegink LD, Appelbaum MI, Kiritsy MC. Effects of diets high in sucrose or aspartame on the behavior and cognitive performance of children. N Engl J Med 1994; 330:301-7.

Milich R, Pelham WE. Effects of sugar ingestion in the classroom and playground behavior of attention deficit disordered boys. J Consult Clin Psychol 1986; 54:714-8.

Wolraich M, Milich R, Stumbo P, Schultz F. Effects of sucrose ingestion on the behavior of hyperactive boys. J Pediatr 1985; 106:675-81.

Culbert TP, Kajander RL, Reaney JB. Biofeedback with children and adolescents: clinical observations and patient perspectives. J Dev Behav Pediatr 1996; 17:342-50.

Lee SW. Biofeedback as a treatment for childhood hyperactivity: a critical review of the literature. Psychol Rep 1991; 68:163-92.

Lazarro I, Gordon E, Whitmont S. Quantified EEG activity in adolescent attention deficit hyperactivity disorder. Clin Electroencephalogr 1998; 29:37-42.

Nash JK. Treatment of attention deficit hyperactivity disorder with neurotherapy. Clin Electroencephalogr 2000; 31:30-7.

Lubar JF, Swartwood MO, Swartwood JN, O'Donnell PH. Evaluation of the effectiveness of EEG neurofeedback training for ADHD in a clinical setting as measured by changes in T.O.V.A. scores, behavioral ratings, and WISC-R performance. Biofeedback Self Regul 1995; 20:83-99.

Gross-Tsur V, Manor O, van der Meere J, Joseph A, Shalev RS. Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective? J Pediatr 1997; 130:670-4.

Connor DF, Fletcher KE, Swanson JM. A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 1999; 38:1551-9.

- Association canadienne pour la santé mentale

- Société canadienne de pédiatrie